10 June 2020

Study team appointed for the new UK EQ-5D-5L valuation study

Dr Donna Rowen from ScHARR has been appointed as Principal investigator for the new UK EQ-5D-5L valuation study.

SCHARR Regent Court building and courtyard

The ScHARR team also includes Dr Clara Mukuria and Professor John Brazier. ScHARR will be collaborating with researchers from Bangor University, PHMR, Queens University Belfast, University of Leeds and University of Oxford. ScHARR is one of the collaborating sites conducting interviews.

The Principal Investigator, Donna Rowen, welcomed the appointments; “The UK research team working across 6 sites are looking forward to collaborating together to generate the much needed EQ-5D-5L value set for the UK.”

The Steering Group has representatives from National Institute for Health and Care Excellence (NICE), Department of Health and Social Care, NHS England, the EuroQol Research Foundation and academic experts. Independent Quality Control will be built in to every stage of the project. Data collection is expected to begin in early 2021.

For further details including the wider study team see: https://euroqol.org/study-team-appointed-for-the-new-uk-eq-5d-5l-valuation-study/.